Which one, gastric parietal cell antibody positivity or hyperhomocysteinemia, is a better biomarker to predict oral mucosal disease patients with vitamin B12 deficiency?

Andy Sun; Julia Yu Fong Chang; Chun Pin Chiang

doi:10.1016/j.jfma.2020.08.017

Which one, gastric parietal cell antibody positivity or hyperhomocysteinemia, is a better biomarker to predict oral mucosal disease patients with vitamin B12 deficiency?

Andy Sun, Julia Yu Fong Chang, Chun Pin Chiang

Institute of Dental Medicine and Materials(Master Program)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	906-907
Number of pages	2
Journal	Journal of the Formosan Medical Association
Volume	120
Issue number	2
DOIs	https://doi.org/10.1016/j.jfma.2020.08.017
State	Published - Feb 2021

Access to Document

10.1016/j.jfma.2020.08.017

Cite this

@article{e23e76ee3eb74f4998e56001a5895a50,

title = "Which one, gastric parietal cell antibody positivity or hyperhomocysteinemia, is a better biomarker to predict oral mucosal disease patients with vitamin B12 deficiency?",

author = "Andy Sun and Chang, \{Julia Yu Fong\} and Chiang, \{Chun Pin\}",

year = "2021",

month = feb,

doi = "10.1016/j.jfma.2020.08.017",

language = "英语",

volume = "120",

pages = "906--907",

journal = "Journal of the Formosan Medical Association",

issn = "0929-6646",

publisher = "Elsevier B.V.",

number = "2",